TEVA - Teva gains U.S. approval for generic version of osteoporosis injection
2023-11-17 09:26:34 ET
More on Teva Pharmaceutical
- Teva Pharmaceutical Industries Limited (TEVA) Q3 2023 Earnings Call Transcript
- Teva Pharmaceutical Industries Limited 2023 Q3 - Results - Earnings Call Presentation
- Teva: Focus On Innovation And Growth Means The Times They Are A Changing
- Teva inks $125M deal with Royalty Pharma to develop antipsychotic drug
- 6 stocks to watch on Wednesday: Teva, Roblox, Disney, Spirit AeroSystems and more
For further details see:
Teva gains U.S. approval for generic version of osteoporosis injection